Ambys Medicines Announces Appointment of Founder Markus Grompe, M.D., as Chief Scientific Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Ambys Medicines, a company aiming to be the leader in cell therapy for severe liver disease by unlocking the full potential of hepatocyte transplantation, today announced the appointment of Markus Grompe, M.D., as the company’s Chief Scientific Officer. Dr. Grompe is a world-leading expert on stem...

Click to view original post